Western Sierra R (WSRC) Stock Price, News & Analysis
Company Description
Western Sierra R (OTC Link: WSRC) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $67.4K.
WSRC has declined 50.0% over the past year. Shares last traded at $0.0001.
This page collects what Stock Titan holds for WSRC, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Western Sierra R (WSRC) stock last closed at $0.0001. Over the past 12 months, the stock has lost 50.0%. At a market capitalization of $67.4K, WSRC is classified as a micro-cap stock with approximately 337.1M shares outstanding.
Latest News
Western Sierra R has 10 recent news articles. Of the recent coverage, 9 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition. View all WSRC news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
WSRC Company Profile & Sector Positioning
Western Sierra R (WSRC) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing WSRC often look at related companies in the same sector, including Rising Biosciences (RBII), Hero Technologies Inc (HENC), Evergreen Sustainable Enterprises Inc (EGSE), Owc Pharmaceutical Resh Corp (OWCP), and Cannonau Corp (CNNC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate WSRC's relative position within its industry.